{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most prevalent known cause of autosomal dominant Parkinson's disease (PD). The LRRK2 gene encodes a Roco protein featuring a ROC GTPase and a kinase domain linked by the C-terminal of ROC (COR) domain.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that LRRK2 mutations are a major cause of PD, linking the gene to a disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Here, we explored the effects of the Y1699C pathogenic LRRK2 mutation in the COR domain on GTPase activity and interactions within the catalytic core of LRRK2.",
          "judgment": "Yes",
          "reasoning": "Assessing GTPase activity and protein interactions are relevant to understanding LRRK2 function and its role in PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 1a"
        },
        {
          "step_name": "Step 1a: Basic Controls and Replicates",
          "extracted_paper_info": "We observed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "Yes",
          "reasoning": "The paper uses a comparison with known pathogenic and dysfunctional mutants (R1441C and T1348N) as a form of control, indirectly demonstrating a comparison to a functional 'normal' state.",
          "next_step_or_outcome": "Proceed to Step 1b"
        },
        {
          "step_name": "Step 1b: Variant Controls",
          "extracted_paper_info": "We observed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "Yes",
          "reasoning": "The comparison to R1441C and T1348N serves as variant controls, demonstrating what level of diminished function is expected in known pathogenic variants.",
          "next_step_or_outcome": "Proceed to Step 1c"
        },
        {
          "step_name": "Step 1c: Statistical Analyses",
          "extracted_paper_info": "We observed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "No",
          "reasoning": "The text does not provide any specific statistical analyses, p-values, or OddsPath calculations. It only states a 'comparable decrease'.",
          "next_step_or_outcome": "Proceed to Sub-step 1d"
        },
        {
          "step_name": "Sub-step 1d: No OddsPath Calculation",
          "extracted_paper_info": "N/A",
          "judgment": "N/A",
          "reasoning": "No statistical analysis was done",
          "next_step_or_outcome": "Proceed to outcome"
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting"
    }
  ]
}